Follow our progress.

Genomic Health Announces Second Quarter 2012 Financial Results and Business Progress

• Product Revenue Increased 13% Compared with Prior Year 
• Delivered Net Income of $1.8 Million 
• Began Offering Oncotype DX® Colon Cancer Test for Stage III Patients 
• Combined Invitae with Locus Development to Create Independent Genetics Company 
• Conference Call Today at 4:30 p.m. ET 

REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June ...

Genomic Health Announces Formation of New Genetics Subsidiary

REDWOOD CITY, Calif., Feb. 6, 2012 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.   The subsidiary is expected to be established by March 1, 2012 and provide its first commercial service in 2013.  The new venture will be ...